Wells Fargo
DARE icon

Wells Fargo’s Dare Bioscience DARE Stock Holding History

Wells Fargo’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64
Closed -$378 – 7023
2024
Q1 		$378 Buy
64
+1
+2% +$5 ﹤0.01% 6347
2023
Q4 		$234 Buy
63
+10
+19% +$46 ﹤0.01% 6572
2023
Q3 		$296 Buy
53
+1
+2% +$8 ﹤0.01% 6481
2023
Q2 		$565 Buy
52
+3
+6% +$36 ﹤0.01% 6460
2023
Q1 		$610 Buy
49
+1
+2% +$13 ﹤0.01% 6504
2022
Q4 		$480 Sell
48
-832
-95% -$9.3K ﹤0.01% 6399
2022
Q3 		$11K Buy
880
+666
+311% +$9.15K ﹤0.01% 5639
2022
Q2 		$3K Buy
214
+8
+4% +$120 ﹤0.01% 6166
2022
Q1 		$4K Buy
206
+170
+472% +$3.21K ﹤0.01% 6517
2021
Q4 		$1K Buy
36
+11
+44% +$226 ﹤0.01% 6984
2021
Q3 		$1K Buy
25
+1
+4% +$20 ﹤0.01% 6682
2021
Q2 		$1K Buy
24
+4
+20% +$68 ﹤0.01% 6641
2021
Q1 		$0 Buy
20
+1
+5% +$24 ﹤0.01% 6942
2020
Q4 		$0 Buy
19
+4
+27% +$56 ﹤0.01% 6541
2020
Q3 		$0 Buy
15
+4
+36% +$53 ﹤0.01% 6394
2020
Q2 		$0 Hold
11
– – ﹤0.01% 6348
2020
Q1 		$0 Buy
+11
New +$148 ﹤0.01% 6280
2019
Q4 		– Sell
-83
Closed -$1K – 6387
2019
Q3 		$1K Buy
+83
New +$794 ﹤0.01% 6259
2016
Q1 		– Sell
-1,847
Closed -$621K – 6233
2015
Q4 		$621K Buy
+1,847
New +$766K ﹤0.01% 3784

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wells Fargo's DARE Position: Q2 2024 in Review

Wells Fargo sold out of Dare Bioscience (DARE) in Q2 2024, closing a stake of 64 shares — an estimated $378 sold.

Wells Fargo first reported a position in DARE in Q4 2015 and held it in 19 quarters. The position peaked at $621K in Q4 2015. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2024.

  • Wells Fargo reported no remaining Dare Bioscience position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 64 Dare Bioscience shares in Q2 2024, an estimated $378.
  • Wells Fargo first reported a position in Dare Bioscience in Q4 2015 and held it in 19 quarters.
  • Wells Fargo's Dare Bioscience position peaked at $621K in Q4 2015.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.